Source: Business Standard

Sequent Medical: Terumo acquires Sequent Medical for $ 280 mn

The acquisition of US-based developer of new aneurysm embolization device will help Terumo to expand its presence in the global neurovascular device market

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas C. Wilder's photo - President & CEO of Sequent Medical

President & CEO

Thomas C. Wilder

CEO Approval Rating

68/100

Read more